Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 250 /hr
Hire Dr. Morassa M.
United States
USD 250 /hr
Genomics & Diagnostics Product Strategy Consultant | Technical Due Diligence | NGS, cfDNA/NIPT, IVD
Profile Summary
Subject Matter Expertise
Services
Research
Market Research
Consulting
Business Strategy Consulting,
Scientific and Technical Consulting,
Regulatory Consulting
Product Development
Product Evaluation,
Product Validation,
Quality Assurance & Control (QA/QC),
Product Compliance ,
Concept Development,
Product Launch Support
Work Experience
SVP, Product & Commercial Strategy
Swan Genomics
August 2024 - Present
Founder
M3 Advisory, LLC
January 2022 - Present
VP, Product Development & Scientific Operations
Encodia
December 2021 - April 2024
Senior Director, Genomic Applications & Collaborations
PacBio (formerly Omniome)
August 2017 - December 2021
Head of Product Care & Global Customer Support, cfDNA/ctDNA
Roche (United States)
2014 - 2017 ![]()
Director, Technical Services
Ariosa
2012 - 2014 ![]()
Education
PhD, Human Genetics & Molecular Biology
Johns Hopkins University
January 2006 - January 2011
PhD, Human Genetics & Molecular Biology
Johns Hopkins University
2006 - 2011 ![]()
Certifications
Publications
JOURNAL ARTICLE
Cidado J, Wong HY, Rosen DM, Cimino-Mathews A, Garay JP, Fessler AG, Rasheed ZA, Hicks J, Cochran RL, Croessmann S, et al.(2016). Ki-67 is required for maintenance of cancer stem cells but not cell proliferation . Oncotarget.
Croessmann S, Wong HY, Zabransky DJ, Chu D, Mendonca J, Sharma A, Mohseni M, Rosen DM, Scharpf RB, Cidado J, et al.(2015). NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability . Proceedings of the National Academy of Sciences of the United States of America.
Blair BG, Wu X, Zahari MS, Mohseni M, Cidado J, Wong HY, Beaver JA, Cochran RL, Zabransky DJ, Croessmann S, et al.(2014). A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations . Proteomics.
Mohseni M, Cidado J, Croessmann S, Cravero K, Cimino-Mathews A, Wong HY, Scharpf R, Zabransky DJ, Abukhdeir AM, Garay JP, et al.(2014). MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers . Proceedings of the National Academy of Sciences of the United States of America.
Wu X, Renuse S, Sahasrabuddhe NA, Zahari MS, Chaerkady R, Kim MS, Nirujogi RS, Mohseni M, Kumar P, Raju R, et al.(2014). Activation of diverse signalling pathways by oncogenic PIK3CA mutations . Nature communications.
Juneau K, Bogard PE, Huang S, Mohseni M, Wang ET, Ryvkin P, Kingsley C, Struble CA, Oliphant A, Zahn JM(2014). Microarray-based cell-free DNA analysis improves noninvasive prenatal testing . Fetal diagnosis and therapy.
Wang GM, Wong HY, Konishi H, Blair BG, Abukhdeir AM, Gustin JP, Rosen DM, Denmeade SR, Rasheed Z, Matsui W, et al.(2013). Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation . Cancer research.
Garay JP, Karakas B, Abukhdeir AM, Cosgrove DP, Gustin JP, Higgins MJ, Konishi H, Konishi Y, Lauring J, Mohseni M, et al.(2012). The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation . Breast cancer research : BCR.
Konishi H, Mohseni M, Tamaki A, Garay JP, Croessmann S, Karnan S, Ota A, Wong HY, Konishi Y, Karakas B, et al.(2011). Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells . Proceedings of the National Academy of Sciences of the United States of America.
Higgins MJ, Beaver JA, Wong HY, Gustin JP, Lauring JD, Garay JP, Konishi H, Mohseni M, Wang GM, Cidado J, et al.(2011). PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells . Cancer biology & therapy.
Mohseni M, Park BH(2010). PIK3CA and KRAS mutations predict for response to everolimus therapy: now that's RAD001 . The Journal of clinical investigation.
Lauring J, Cosgrove DP, Fontana S, Gustin JP, Konishi H, Abukhdeir AM, Garay JP, Mohseni M, Wang GM, Higgins MJ, et al.(2010). Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations . Oncogene.
Karnan S, Mohseni M, Konishi Y, Tamaki A, Hosokawa Y, Park BH, Konishi H(2009). Controversial BRCA1 allelotypes in commonly used breast cancer cell lines . Breast cancer research and treatment.
Gustin JP, Karakas B, Weiss MB, Abukhdeir AM, Lauring J, Garay JP, Cosgrove D, Tamaki A, Konishi H, Konishi Y, et al.(2009). Knockin of mutant PIK3CA activates multiple oncogenic pathways . Proceedings of the National Academy of Sciences of the United States of America.